BioHarvest Sciences CMO shares personal connection to VINIA supplement in Collision keynote
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) chief medical officer Dr. Brian Cornblatt can speak to the effectiveness of the company's red grape-based...
Stay updated with breaking news from Brian Cornblatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) chief medical officer Dr. Brian Cornblatt can speak to the effectiveness of the company's red grape-based...
VINIA® revenues grew 209% compared to Q1 2022 to reach USD 2.2 MReiterating guidance for year-on-year revenue growth of 3 X to reach USD 17M+ Gross margins continue to improve towards target required
NFL wide receiver-turned-trainer Yo Murphy educates players on the importance of using science-based solutions like VINIA® to optimize their heart health and general wellness during and after sports
Study will assess the Capacity of its Red Grape Cell (RGC) Botanical Composition to Promote Eye HealthStudy is first to demonstrate potential capabilities of BioHarvest's Botanical-Synthesis technology
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has announced a clinical trial assessing the capacity of its red grape cell (RGC) composition to promote eye...